Apollo Hospitals Enterprise Ltd.

Apollo Hospitals is currently trading at Rs. 617.90, up by 21.05 points or 3.53% from its previous closing of Rs. 596.85 on the BSE.

The scrip opened at Rs. 584.05 and has touched a high and low of Rs. 622.90 and Rs. 584.05 respectively. So far 48817 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 716.90 on 05-Dec-2011 and a 52 week low of Rs. 432.30 on 24-Jun-2011.

Last one week high and low of the scrip stood at Rs. 622.90 and Rs. 584.05 respectively. The current market cap of the company is Rs. 8094.22 crore.

The promoters holding in the company stood at 33.10% while Institutions and Non-Institutions held 34.44% and 31.15% respectively.

Apollo Hospitals has rolled out an MRI-guided high intensity focused ultrasound solution from Philips Healthcare to offer non-invasive treatment of uterine fibroids in women. As per the traditional treatment, women have to undergo surgery and a long road to recovery, which takes up several months to recover. The solution is currently available in four Apollo hospitals - in Chennai, Delhi, Bangalore and Hyderabad and it plans to expand to other centers as well.

MRI-guided ultrasound solution will be helpful as it involves no radiation, no scar, no anesthesia, recovery time of just a day, more precise magnetic resonance image guided treatment. Traditional surgery costs Rs 40,000-60,000 at Apollo, the new solution will cost Rs 70,000-90,000. The cost of the Philips machine imported from Helsinki is Rs 5 crore.

Apollo Hospitals, is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.